A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors 
Baron & Budd Investigates Potential Electronic Health Records Fraud Cases
Whistleblowers who have information about EHR fraud may bring lawsuits under the False Claims Act. WASHINGTON--(BUSINESS WIRE)--Today, the national law...
StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA
First-ever mRNA gene expression, multi-cancer panel simultaneously screens for multiple cancers from a single sample of bloodTORONTO, ON and RICHMOND,...
cbdMD To Attend Jefferies Cannabis Summit On June 2nd In NYC
Charlotte, North Carolina--(Newsfile Corp. - May 25, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the...
SummaForte(TM) Adds Two World-Class Leaders in Sports Medicine and Physical Therapy to Advisory Team
Bloomington, Indiana--(Newsfile Corp. - May 25, 2022) - SummaForte has added two respected experts in sports medicine and physical therapy...
Elixxer Ltd. Closes Amended Secured Loan with AIP Convertible Private Debt Fund L.P
Montreal, Quebec--(Newsfile Corp. - May 25, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTC Pink: ELIXF) ("Elixxer" or the "Company) is...
Healthcare Technology Report Names Nym’s Melisa Tucker Among 2022’s “Top 25 Women Leaders In Healthcare Software”
NEW YORK--(BUSINESS WIRE)--Nym Health, a leader in transforming clinical language into actionable information, today announced that its Senior Vice President...
Lumenis OptiLight Wins 2022 MedTech Breakthrough Award: Best New Technology Solution for Ophthalmology
For the third straight year, Lumenis wins award recognizing outstanding medical companies and technologies YOKNE’AM ILLIT, Israel--(BUSINESS WIRE)--Lumenis Be., a...
American Family Care Names New Vice President of Franchise Development
Nation's Largest Urgent Care Provider Appoints Paige Robinson to Lead Expansion EffortsBIRMINGHAM, AL / ACCESSWIRE / May 25, 2022 /...
Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS
The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing...
AlzeCure Presents at Redeye Growth Day on June 2
STOCKHOLM, SWEDEN / ACCESSWIRE / May 25, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
Jaguar Health Announces Napo Therapeutics’ Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition
Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to...
CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development
CureVac is broadening its foundation in oncology, leveraging recent progress with its second-generation mRNA backboneThe partnership combines CureVac's mRNA technology...
Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update
Progressing broad vaccine development program in collaboration with GSK, with second-generation candidates in Phase 1 clinical trials for COVID-19 and...
Tenon Medical, Inc. Announces Upcoming Virtual Conference Participation
LOS GATOS, CA / ACCESSWIRE / May 25, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device...
ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer,...
Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022
Patient Data Suggests Multiple Additional Inflammatory Pathways, Supporting Potential Need for Combination Therapy for Ulcerative Colitis Patient Data Establishes Proof...
Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer
Capricor Expands Senior Management Team to Build Commercial Strategy for Lead Asset, CAP-1002, and Further Develop Partnering Strategy for Proprietary...
Open For Business: Optimi Completes First Grow of Psilocybin Mushrooms and Introduces Head of Cultivation
Company to focus on supply agreements and working directly with Canadians and physicians Head of Cultivation, Todd Henderson First grow...
Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock
CAMBRIDGE, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a...
Senti Bio Names Dr. Kanya Rajangam to Newly Created Position of Chief Medical and Development Officer
Cell therapy and oncology drug development expert aims to lead Senti Bio's novel off-the-shelf CAR-NK cell oncology programs into and...